Reading NNVC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track NNVC free→Reading NNVC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track NNVC free→QuarterlyIQ Insights · NNVC
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Entry into a Material Definitive Agreement. Securities Purchase Agreement On May 15, 2026, NanoViricides, Inc. (the “Company”) and a certain purchaser (the “Investor”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) pursuant to which the Company agreed to sell and issue to the Investor in a registered direct offering (the “Offering”): (i) 1,133,334 shares of common stock, par value $0.00001 per share (the “Common Stock”), at an offering price of $1.50 per sh…
Entry into a Material Definitive Agreement. Securities Purchase Agreement On November 10, 2025, NanoViricides, Inc. (the “Company”) and a certain institutional investor (the “Investor”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) pursuant to which the Company agreed to sell and issue to the Investor in a registered direct offering (the “Registered Direct Offering”): (i) 1,970,000 shares of common stock, par value $0.00001 per share (the “Common Stock”),…
Neither this Current Report on Form 8-K nor any exhibit attached hereto is an offer to sell or the solicitation of an offer to buy shares of Common Stock or other securities of the Company.
Compensatory Arrangements of Certain Officers. Extension Employment Agreement - Anil Diwan On September 25, 2025, NanoViricides, Inc. (the “Registrant”) entered into an Extension Agreement effective July 1, 2025 (the “Diwan Extension”) of the Employment Agreement with Dr. Anil R. Diwan entered into on July 1, 2018 (the “Diwan Employment Agreement”) to continue to serve as the President of the Registrant, effective July 1, 2025. The Extension provides that Dr. Diwan will continue to serve as t…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.